Published: March 16th 2025 | Updated: March 26th 2025
Retina Specialists’ Evolving View on Biosimilars in AMD Treatment
Published: February 25th 2025 | Updated: March 26th 2025
Biosimilar Approvals Streamlined With Advanced Statistics Amidst Differing Regulatory Requirements
Published: February 25th 2025 | Updated: March 26th 2025
3 Ustekinumab Biosimilars Launch on US Market
Published: February 23rd 2025 | Updated: March 26th 2025
Will the FTC Be More PBM-Friendly Under a Second Trump Administration?
Published: February 16th 2025 | Updated: March 26th 2025
Enhancing Biosimilar Adoption in Value-Based Oncology Care
Published: February 4th 2025 | Updated: March 26th 2025
The Banking of Biosimilars: Insights From a Leading Health Economist